Chemotherapy intensification for first-line treatment of poor-prognosis metastatic germ cell cancer is not yet ready for prime time

被引：0
作者：
Jiang, Di Maria [1 ]
Hamilton, Robert J. [2 ]
Hansen, Aaron R. [1 ]
机构：
[1] Univ Toronto, Div Med Oncol & Haematol, Princess Margaret Canc Ctr, Toronto, ON, Canada
[2] Univ Toronto, Div Urol, Dept Surg Oncol, Princess Margaret Canc Ctr, Toronto, ON, Canada
来源：
CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL | 2020年 / 14卷 / 02期
关键词：
PHASE-III; CISPLATIN; IFOSFAMIDE; PACLITAXEL; ETOPOSIDE;
D O I：
10.5489/cuaj.6407
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：48 / 49
页数：2
相关论文
共 50 条
  • [31] Monoclonal Antibodies for First-Line Treatment of Metastatic Colorectal Cancer
    Liao, Pei-Fei
    Wu, Ta-Wei
    Peng, Tzu-Rong
    AMERICAN JOURNAL OF THERAPEUTICS, 2024, 31 (03) : e286 - e297
  • [32] First-Line Treatment of Metastatic Non-Small Cell Lung Cancer in the Elderly
    Losanno, Tania
    Gridelli, Cesare
    CURRENT ONCOLOGY REPORTS, 2021, 23 (10)
  • [33] Use of bevacizumab as a first-line treatment for metastatic breast cancer
    Manso, L.
    Moreno, F.
    Marquez, R.
    Castelo, B.
    Arcediano, A.
    Arroyo, M.
    Ballesteros, A. I.
    Calvo, I.
    Echarri, M. J.
    Enrech, S.
    Gomez, A.
    Gonzalez del Val, R.
    Lopez-Miranda, E.
    Martin-Angulo, M.
    Martinez-Janez, N.
    Olier, C.
    Zamora, P.
    CURRENT ONCOLOGY, 2015, 22 (02) : E51 - E60
  • [34] First-line combination chemotherapy with etoposide, ifosfamide and cisplatin for the treatment of disseminated germ cell cancer: Efficacy and feasibility in current clinical practice
    Fujiwara, Motohiro
    Tanaka, Hajime
    Yuasa, Takeshi
    Komai, Yoshinobu
    Oguchi, Tomohiko
    Fujiwara, Ryo
    Numao, Noboru
    Yamamoto, Shinya
    Fujii, Yasuhisa
    Fukui, Iwao
    Yonese, Junji
    INTERNATIONAL JOURNAL OF UROLOGY, 2021, 28 (09) : 920 - 926
  • [35] Secondary leukemia after first-line high-dose chemotherapy for patients with advanced germ cell cancer
    Wierecky, J
    Kollmannsberger, C
    Boehlke, I
    Kuczyk, M
    Schleicher, J
    Schleucher, N
    Metzner, B
    Kanz, L
    Hartmann, J
    Bokemeyer, C
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2005, 131 (04) : 255 - 260
  • [36] Secondary leukemia after first-line high-dose chemotherapy for patients with advanced germ cell cancer
    J. Wierecky
    C. Kollmannsberger
    I. Boehlke
    M. Kuczyk
    J. Schleicher
    N. Schleucher
    B. Metzner
    L. Kanz
    J. T. Hartmann
    C. Bokemeyer
    Journal of Cancer Research and Clinical Oncology, 2005, 131 : 255 - 260
  • [37] ACORN: Observational Study of Bevacizumab in Combination With First-Line Chemotherapy for Treatment of Metastatic Colorectal Cancer in the UK
    Khakoo, Shelize
    Chau, Ian
    Pedley, Ian
    Ellis, Richard
    Steward, Will
    Harrison, Mark
    Baijal, Shobhit
    Tahir, Saad
    Ross, Paul
    Raouf, Sherif
    Ograbek, Agnes
    Cunningham, David
    CLINICAL COLORECTAL CANCER, 2019, 18 (04) : 280 - +
  • [38] Conditional Survival of Patients Treated With First-Line Chemotherapy for Metastatic Urothelial Cancer
    Santoni, Matteo
    Crabb, Simon J.
    Conti, Alessandro
    Rossi, Lorena
    Burattini, Luciano
    Conteduca, Vincenza
    Chau, Caroline
    Burgio, Salvatore L.
    Muzzonigro, Giovanni
    Cascinu, Stefano
    De Giorgi, Ugo
    CLINICAL GENITOURINARY CANCER, 2015, 13 (03) : 244 - 249
  • [39] Prognostic Factors in First-Line Chemotherapy Treated Metastatic Gastric Cancer Patients: A Retrospective Study
    Inal, Ali
    Kaplan, M. Ali
    Kucukoner, Mehmet
    Urakci, Zuhat
    Guven, Mehmet
    Nas, Necip
    Yunce, Muharrem
    Isikdogan, Abdurrahman
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (08) : 3869 - 3872
  • [40] Preoperative immunochemotherapy versus chemotherapy as first-line treatment for patients with stage I-IIIB small-cell lung cancer
    Zhu, Linhai
    Liu, Jiacong
    Huang, Xuhua
    Hu, Jian
    BMC CANCER, 2025, 25 (01)
12345